Concepedia

Margaretha Grind

MG

Statistics

Publications

17

Citations

1.4K

H-Index

13

Active since

1977

Affiliations

AstraZeneca (Sweden)(Current)

Karolinska Institutet

Birmingham City Hospital

Loughborough University

University of Vienna

Margaretha Grind is an author at AstraZeneca (Sweden) specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

1977–2008

17

Publications

17

Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

Gregory W. Albers, Hans‐Christoph Diener, Lars Frison et al. · JAMA · 2005 · 665 citations

, , +17

Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation

Palle Petersen, Margaretha Grind, John R. Adler · Journal of the American College of Cardiology · 2003 · 190 citations

, , +11

Effect of hypertension on anticoagulated patients with atrial fibrillation

Gregory Y.H. Lip, Lars Frison, Margaretha Grind · European Heart Journal · 2007 · 167 citations · Full text

, , +17

Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation

Gregory Y.H. Lip, Lars Frison, Margaretha Grind · Journal of Internal Medicine · 2008 · 57 citations · Full text

, , +17

Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects

Michael Wolzt, Maria Wollbratt, Mia Svensson et al. · European Journal of Clinical Pharmacology · 2003 · 40 citations

, , +12

1–5 of 17